Jacob Kerkin
Jacob Kerkin is an investment manager at Omni Bridgeway in New Zealand, involved in financing a class action lawsuit aimed at challenging the efficacy of phenylephrine in cold and flu medications sold to consumers.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
4
New Zealand:
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
4